Breaking News
July 17, 2018 - Pre-clinical pilot study shows promising results of ‘concussion pill’
July 17, 2018 - Researchers reduce size of tumors in mice by artificially activating the brain’s reward system
July 17, 2018 - New study documents symptoms of people before they acquire multiple sclerosis
July 17, 2018 - Researchers discover why CRISPR gene editing sometimes fails
July 17, 2018 - New finding may hold key to better understand the complexities of neurological disorders
July 17, 2018 - The Current issue of “The view from here” is concerned with Novel Targets.
July 17, 2018 - Fighting the Flu with a Universal Vaccine
July 17, 2018 - Key social reward circuit in the brain impaired in kids with autism | News Center
July 17, 2018 - Insight into causes, types and treatment of aphasia
July 16, 2018 - Quark Pharmaceuticals, Inc Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
July 16, 2018 - NSAIDs shown to have causal role in cardiovascular risk of patients with osteoarthritis
July 16, 2018 - PET scan tracer predicts success of cancer ‘vaccine’ | News Center
July 16, 2018 - Parents struggle with what to do when their child has headache, shows study
July 16, 2018 - Outrageous or overblown? HHS announces another round of ACA navigator funding cuts
July 16, 2018 - Weight loss surgery may impact individual’s risk of developing cancer, shows study
July 16, 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
July 16, 2018 - Restoring epigenetic balance reinstates memory in flies with Alzheimer’s disease symptoms
July 16, 2018 - Magnetized wire could be used to detect cancer in people | News Center
July 16, 2018 - Non-surgical management found to be feasible option for penetrating kidney trauma
July 16, 2018 - California clinic screens asylum seekers for honesty
July 16, 2018 - FDA Approves Xtandi (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
July 16, 2018 - Can nanotechnology help treat Alzheimer’s?
July 16, 2018 - Researchers identify protein essential for making stem cells | News Center
July 16, 2018 - Radiologist discusses causes, treatments of varicose veins
July 16, 2018 - Researchers develop nanostructured surface to accelerate wound healing after dental implants
July 16, 2018 - New non-invasive procedure to reposition kidney stones could benefit astronauts
July 16, 2018 - Attending Surgeon Influences Genetic Testing in Breast Cancer
July 16, 2018 - Medical doctors with addictions fear professional repercussions if they seek treatment
July 16, 2018 - 5 Questions: John Ioannidis calls for more rigorous nutrition research | News Center
July 16, 2018 - University of Illinois buys 3D-Bioplotter for regenerative biology, tissue engineering research
July 16, 2018 - Charité’s researchers integrate open-source platform into the ‘Human Brain Project’
July 16, 2018 - SUSU scientists develop rehabilitation device for people with lower limbs injuries
July 16, 2018 - Researchers find definite increase in scooter-related injuries
July 16, 2018 - Researchers solve mystery of final blood group system
July 16, 2018 - Researchers develop near-infrared fluorophores-based PDT to cure cancer with less side effects
July 16, 2018 - Traumatic brain injury biomarker could help predict patient prognosis
July 16, 2018 - Researchers to investigate role of hormones in mosquito’s ability to use human blood for egg production
July 16, 2018 - AHA: Doctor Makes Lifesaving House Call in His Own Home
July 16, 2018 - Nearsightedness – Genetics Home Reference
July 16, 2018 - Study shows biomarker panel boosts lung cancer risk assessment for smokers
July 16, 2018 - Researchers find link between bereavement during pregnancy, child’s mental health | News Center
July 16, 2018 - Legalizing same-sex marriage has meaningful effects on health care access for sexual-minority men
July 16, 2018 - New York to allow medical marijuana as substitute to opioids
July 16, 2018 - Reducing tapeworm infection could improve academic performance, reduce poverty | News Center
July 16, 2018 - Researchers describe key role of enzyme in regulating immune response against Chagas disease parasite
July 16, 2018 - Johnson & Johnson Announces Publication in The Lancet Highlighting Robust Immune Response to Janssen’s Mosaic-based Preventive Vaccine Regimen for HIV
July 16, 2018 - Do Racial and Gender Disparities Exist in Newer Glaucoma Treatments?
July 16, 2018 - Antibodies may predict transplant rejection risk
July 16, 2018 - New center sets out to stop disease before it starts | News Center
July 16, 2018 - FDA warns consumers about criminals sending fake warning letters
July 16, 2018 - Residential segregation linked with racial disparities in firearm homicide fatalities
July 16, 2018 - UW-Madison researchers develop new method to track Parkinson’s damage in the heart
July 16, 2018 - New approach to cultivate hypoallergenic tomato and strawberry varieties
July 16, 2018 - Smoking associated with delayed shinbone healing
July 16, 2018 - Sheila Dolezal, ‘team player extraordinaire,’ wins 2018 Amy J. Blue Award | News Center
July 16, 2018 - Advanced Prostate Cancer Variant More Common Than Thought
July 16, 2018 - New ways to conquer sleep apnea compete for place in bedroom
July 16, 2018 - Renowned microbe hunter Stanley Falkow dies at 84 | News Center
July 15, 2018 - FDA Slaps Stronger Warnings on Potent Class of Antibiotics, Fluoroquinolones
July 15, 2018 - Don’t let depression keep you from exercising
July 15, 2018 - Student research symposium showcases curiosity and scholarship | News Center
July 15, 2018 - Heavy smokers have increased risk of heart rhythm disorder, shows study
July 15, 2018 - Parents who had severe trauma, stresses in childhood more likely to have kids with behavioral health problems
July 15, 2018 - At colloquium, a range of views on value of predictive algorithms | News Center
July 15, 2018 - Pittcon invites oral and poster presentations for 2019 Technical Program
July 15, 2018 - Virtual reality could offer psychotherapy for fear of heights, study shows
July 15, 2018 - Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes
July 15, 2018 - Kolon TissueGene To Start US Phase III Clinical Trial For Invossa
July 15, 2018 - Study finds prenatal marijuana use can affect infant size, behavior
July 15, 2018 - Howard Chang named HHMI investigator | News Center
July 15, 2018 - Study shows tailored mental health services improve wellbeing of emerging adults
July 15, 2018 - A bright future might help teens steer clear of violence
July 15, 2018 - Stanford Medicine magazine explores the art, science of listening and hearing | News Center
July 15, 2018 - New study tracks how the brain turns simple sensory inputs into meaningful categories
July 15, 2018 - Deadlier subtype of metastatic prostate cancer found to be common than previously thought
July 15, 2018 - UZH scientists identify enzyme that controls cell division
July 15, 2018 - Unhealthy Food Behaviors May Signal Eating Disorder in Teen
July 15, 2018 - Study raises doubts on a previous theory of Parkinson’s disease
July 15, 2018 - Grant awarded to study whether stem cells can treat urinary incontinence | News Center
July 15, 2018 - Imaging techniques may help assess immune system recovery in HIV patients
Raising Awareness of Childhood Dementia

Raising Awareness of Childhood Dementia

image_pdfDownload PDFimage_print

An interview with Professor Paul Gissen, conducted by Kate Anderton, BSc

What is childhood dementia, how common is it?

Childhood dementia is a group of conditions which can occur at any time during childhood.

Credit: Evgeny Atamanenk/Shutterstock.com

Fortunately, it is not very common. If you take each individual disorder, the frequency could be between one in twenty thousand people in the population, to one in a million in the population. But if you take the whole group, then the prevalence will probably be one in 10 thousand or even more frequent than that.

What causes childhood dementia? Are the symptoms similar to adult dementia?

Many gene defects have been linked to childhood dementia. Often, these genetic abnormalities are the same ones that cause dementia in adults, but the more severe forms are linked to childhood dementia. The mutations can either be sporadic, autosomal dominant or autosomal recessive, meaning the child can either inherit the mutation from one or both parents, or neither.

Childhood dementia is mostly caused by single gene defects. One example is CLN2 type Batten disease which is a disorder caused by a mutation in the gene that affects the function of lysosomes. These are cellular organelles that are involved in the recycling of proteins, fats and other materials.

Defects in lysosomal function can lead to an accumulation of molecules in the cell, ultimately resulting in cell death. Childhood dementia can also be caused by primary defects affecting other organelles in the cell, such as, for example, peroxisomes.

In most cases, the symptoms are identical to dementia in adults. Patients may develop completely normally from birth, and show no signs of the disease for the first few years of life. However, at some point, they start losing the skills required for development.

To start with, children may appear more clumsy than usual and certain movements become more difficult. Over time, they lose their ability to walk independently and become completely reliant on their parents for support.

Slowly, the child begins to lose their ability to communicate, and their speech becomes more and more difficult to understand. They struggle to learn new words compared to their peers, and slowly stop being able to form sentences. After that, only occasional words or occasional syllables that can be heard.

Children with dementia also lose the ability to retain information. They struggle to remember things in the near past and of course, when you lose the ability to remember things, learning becomes extremely difficult.

In some types of childhood dementia, such as CLN2, children can also lose their vision. This is a gradual process that, after many years, causes them to go blind. In other forms of dementia, such as Niemann Pick type C disease, children may lose their ability to hear.

How is childhood dementia diagnosed, what is the typical age of onset?

As I said, there are various conditions that can cause childhood dementia. In a specific example, patients with CLN2 disease (a type of Batten Disease) typically show a normal developmental profile until they are about the age of three. After that, they suddenly begin to lose their speech, and start having epileptic seizures. They become clumsy, and then slowly start losing their vision.

Often, the first seizure occurs around the age of three, and by four and a half years old, most children with this condition are unable to walk. By the age of about six, their vision will be significantly impaired and sadly, most children will die by the age of 10 years old.

As childhood dementia encompasses a group of conditions, it is difficult to diagnose using one test. Some of the conditions can be diagnosed quite simply by sending a blood test to the laboratory, and testing for a specific enzyme function. For example, CLN2 type Batten Disease is caused by a lack of an enzyme called TPP1, function of which can be assayed in the blood of the patient.

The problem with diagnosing childhood dementia early is that the initial symptoms are non-specific, so they’re often not considered important. These diseases are rare and most of the general practitioners and even general pediatricians, don’t see these conditions very frequently. They will have seen maybe one case in their working life, sometimes none, and if they don’t think about these conditions, they may not order specific tests to diagnose them.

Why is it important to raise awareness of childhood dementia?

It’s important to raise awareness of childhood dementia in the medical community so that physicians start to recognize that a child who is presenting with clumsiness after developing completely normally for the first few years of life, or whose speech is deteriorating, may have one of the forms of childhood dementia. Children may be labelled as “lazy”, instead of being investigated for the condition.

Just knowing the diagnosis makes a huge difference, because then the parents don’t have to go for continuous testing and assessments. In addition, being able to say to the school and everyone else that their child has a specific condition that will require counseling and extra help, is extremely important.

There are also therapies that are being developed, and some that are already available, that can help with the symptoms or even prevent deterioration. Having the diagnosis enables children to be enrolled onto clinical research trials and have access to these novel therapies.

What are the aims of the ‘Dementia Strikes Children Too’ campaign?

The Dementia Strikes Children Too campaign was set up to raise awareness of childhood dementia among physicians and parents. We wanted to make it known that these conditions, although rare individually, are not so rare when they’re taken as a group and that they must be diagnosed.

At the moment, children can wait up to 10 years for a diagnosis. Being able to reduce this delay was incredibly important to us. These are devastating  conditions. Imagine that your child has been developing normally and then suddenly they begin to lose all their skills and die early, sometimes in pain. If we can prevent that as well by developing novel treatments, that’s a big deal.

Even without the new treatments coming in, the support that can be provided now is quite important. Both psychologically as well as medically.

Where can readers find out more information?

About Professor Paul Gissen

Paul Gissen is the Head of “Genetics and Genomic Medicine” academic programme at the UCL GOS Institute of Child Health and Honorary Consultant in Paediatric Metabolic Diseases at Great Ormond Street Hospital.

In 1995, Paul graduated with a medical degree with commendation from the University of Glasgow. He went on to complete paediatrics training at Manchester, Sheffield and Birmingham Children’s hospitals with specialization in Inherited Metabolic Disorders.

Paul completed a PhD at Birmingham University, where he studied the genetics of rare paediatric metabolic disorders and became interested in molecular and cellular basis of intracellular trafficking disorders.

Paul moved his lab to UCL MRC Laboratory for Molecular and Cell Biology in 2011 and has continued to carry out research at the Great Ormond Street Hospital for Children. His current research focuses on development of novel therapies for children with inherited metabolic disorders.

Tagged with:

About author

Related Articles